All entities
norm: vir biotechnologyUSno LEI · CIK 0001706431Max severity: High
Canonical registry
Vir Biotechnology, Inc.
ent_00b09c6ff1cd8276bcc4dafa
Disclosures
2
Leak Site · State AG · 2 jurisdictions
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
9
as filed · State AG MA
Leak-site claims
1
unverified actor claims
Identity resolution
- Canonical name
- Vir Biotechnology, Inc.
- Normalized
- vir biotechnology— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- 0001706431
- Domain
- None on record
Disclosure history (2)newest first
- GLOBALLeak Siteas victim2025-09-24
Vir Biotechnology is a clinical-stage immunology company that focuses on combining immunologic insights with technologies to treat and prevent serious infectious diseases. The company was founded in 2016 and is headquartered in San Francisco, California
- Massachusetts State AGas victim2021-05-21
Vir Biotechnology, Inc. reported a data breach to the Massachusetts Office of Consumer Affairs and Business Regulation. The breach was reported on 2021-05-21. 9 Massachusetts residents were affected. The report records the breach type as electronic.